Pharmafile Logo
Pharmafocus logo
Advanced Search

Gaucher

Showing 11 posts of 11 posts found.

Genzyme image

Sanofi Gaucher drug approved in Europe

January 22, 2015
Sales and Marketing Cerdelga, Cerezyme, Gaucher, Sanofi, eliglustat, imiglucerase

The European Commission has approved Sanofi-owned Genzyme’s Cerdelga for the treatment of Gaucher disease Type 1.Designed for a condition that …

News
Sanofi image

Priority review for Gaucher drug

December 12, 2013
Sales and Marketing EMA, FDA, Gaucher, Genzyme, Sanofi

The FDA is to conduct a speedy investigation into Sanofi’s twice-daily oral candidate for Gaucher disease, which means that Cerdelga …

News
Pfizer image

Pfizer Gaucher drug rejected by CHMP

June 25, 2012
Sales and Marketing Elelyso, FDA, Gaucher, Pfizer, Shire, Vpriv

A European committee has refused marketing authorisation for Pfizer’s Gaucher disease drug Elelyso, as a competitor drug has exclusivity to …

News

Pfizer enters Gaucher disease market

May 3, 2012
Sales and Marketing Cerezyme, Elelyso, Gaucher, Genzyme, Pfizer, Shire, Vpriv

Pfizer has gained FDA approval for its new Gaucher disease drug Elelyso.  Elelyso (taliglucerase alfa) is an enzyme replacement therapy …

News

Shire facility could answer rare disease drug shortage

November 27, 2011
Manufacturing and Production Fabry disease, Gaucher, Shire, Vpriv

Shire has filed applications with the European and US regulators to produce its Gaucher disease drug Vpriv (velaglucerase alfa) at …

News

More woe for Genzyme as shipping delays continue

July 6, 2010
Manufacturing and Production Cerezyme, Fabrazyme, Gaucher, Genzyme, manufacturing compliance

Genzyme is expecting further delays in shipments of two key products as it struggles to bring its troubled Allston Landing …

News

Shire’s Vpriv recommended for European approval

June 28, 2010
Sales and Marketing Brinavess, Gaucher, Rapiscan, Ruconest, Shire, Sycrest

Shire has won backing from a key European regulatory committee for its new Gaucher disease orphan drug. Vpriv was one …

News

FDA flexes muscles over ailing Genzyme plant

March 29, 2010
Manufacturing and Production Cerezyme, Fabrazyme, Gaucher, Genzyme, manufacturing compliance

Manufacturing compliance problems continue to weigh down US biotechnology company Genzyme, with the US Food and Drug Administration now saying …

News
IcahnWebV

Predatory Icahn moves in on weakened Genzyme

February 23, 2010
Research and Development, Sales and Marketing Gaucher, Genzyme, Icahn

Corporate raider Carl Icahn has made a bid to gain control of beleaguered Genzyme as it struggles to overcome major …

News
Shire

Shire files for Gaucher drug in Europe

December 1, 2009
Sales and Marketing Cerezyme, Gaucher, Shire

 Shire has followed up its marketing applications for Gaucher disease treatment velaglucerase alfa in the US and Canada with a …

News

Genzyme says Cerezyme shortages could last longer than expected

August 17, 2009
Research and Development, Sales and Marketing Gaucher, Genzyme

The shortage of Genzyme's enzyme replacement therapy Cerezyme look set to last longer than expected, as the company has taken …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025